Medication info
BILDADUO M Table 50/850mg (Vildagliptin, Metformin Hydrochloride)

BILDADUO M Table 50/850mg (Vildagliptin, Metformin Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Vildagliptin›50mg / 1 tabletMetformin Hydrochloride›850mg / 1 tablet
Manufacturer / importer
Mothers Pharmaceuticals Co., Ltd.
Appearance
Yellow oval film-coated tablets
Packaging
Bottle - 30 tablets/bottle, Bottle - 100 tablets/bottle
Approval status
Active

MFDS item code 202302532 · Approved 2023.08.25 · Insurance code 622805140

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
For the treatment of patients with type 2 diabetes mellitus, the dose of this medicine should be individualized based on efficacy and tolerability, without exceeding 100mg of vildagliptin and 2000mg of metformin. Doses of vildagliptin greater than 100mg per day are not recommended. This medicine should generally be taken with food or immediately after a meal to reduce gastrointestinal adverse reactions caused by metformin. 1. Patients with no prior experience of antidiabetic drug treatment and inadequate glycemic control with monotherapy: The initial dose is 1 tablet of this medicine 50/500mg once daily. The dose may be gradually increased up to 1 tablet of 50/1000mg twice daily. 2. Patients whose blood glucose is not adequately controlled with metformin monotherapy: The initial dose is 100mg of vildagliptin per day and the patient's existing dose of metformin. The initial dose of this medicine is determined based on the patient's current treatment regimen. Take 1 tablet of this medicine 50mg/850mg or 50mg/1000mg twice daily, in the morning and evening. 3. Patients switching from combination therapy with vildagliptin and metformin: Patients switching from combination therapy with vildagliptin and metformin to this medicine may start at their existing doses of vildagliptin and metformin. 4. Use in combination with a sulfonylurea or insulin: Administer vildagliptin 50mg twice daily (total daily dose 100mg) and metformin at a dose similar to the existing dose. - When this medicine is used in combination with a sulfonylurea, a reduction in the sulfonylurea dose may be necessary to reduce the risk of hypoglycemia. If you forget to take this medicine, take it with your next meal unless it is time to take the missed dose. Do not take a double dose at one time to make up for a missed dose.

Ingredients

Manufacturer
Mothers Pharmaceuticals Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medication helps patients with type 2 diabetes control their blood sugar more effectively. It is especially suitable for those who also engage in diet control and exercise. The components of vildagliptin and metformin work together to stabilize blood sugar management efficiently. Regular intake will aid in improving blood sugar levels. This medication is used to enhance blood sugar control for patients.

How to take

Adult dose

For the treatment of patients with type 2 diabetes mellitus, the dose of this medicine should be individualized based on efficacy and tolerability, without exceeding 100mg of vildagliptin and 2000mg of metformin. Doses of vildagliptin greater than 100mg per day are not recommended. This medicine should generally be taken with food or immediately after a meal to reduce gastrointestinal adverse reactions caused by metformin. 1. Patients with no prior experience of antidiabetic drug treatment and inadequate glycemic control with monotherapy: The initial dose is 1 tablet of this medicine 50/500mg once daily. The dose may be gradually increased up to 1 tablet of 50/1000mg twice daily. 2. Patients whose blood glucose is not adequately controlled with metformin monotherapy: The initial dose is 100mg of vildagliptin per day and the patient's existing dose of metformin. The initial dose of this medicine is determined based on the patient's current treatment regimen. Take 1 tablet of this medicine 50mg/850mg or 50mg/1000mg twice daily, in the morning and evening. 3. Patients switching from combination therapy with vildagliptin and metformin: Patients switching from combination therapy with vildagliptin and metformin to this medicine may start at their existing doses of vildagliptin and metformin. 4. Use in combination with a sulfonylurea or insulin: Administer vildagliptin 50mg twice daily (total daily dose 100mg) and metformin at a dose similar to the existing dose. - When this medicine is used in combination with a sulfonylurea, a reduction in the sulfonylurea dose may be necessary to reduce the risk of hypoglycemia. If you forget to take this medicine, take it with your next meal unless it is time to take the missed dose. Do not take a double dose at one time to make up for a missed dose.

Precautions

This medication can cause severe lactic acidosis or hypoglycemia, so it should not be used in patients with moderate to severe renal impairment or in patients with heart failure, acute myocardial infarction, or sepsis. Moreover, this medication should be discontinued 48 hours prior to procedures using radiographic contrast agents and can be resumed only after confirming normal kidney function post-examination. It should also not be administered to patients with allergic reactions to this medication, type 1 diabetes patients, or patients with acute metabolic acidosis. In cases of severe infections or severe trauma leading to poor systemic condition, this medication should be temporarily discontinued and can be restarted after the condition improves. It is safest for pregnant or breastfeeding women to avoid this medication. Risk of hypoglycemia and lactic acidosis exists when meals are irregular, intense exercise is undertaken, or it is combined with other drugs, so caution is warranted. This medication should also be used cautiously in patients with liver dysfunction, pulmonary dysfunction, excessive alcohol intake, dehydration, diarrhea, or vomiting. While taking this medication, liver function and kidney function should be regularly monitored to ensure no abnormalities arise, especially in the elderly, as they may have reduced kidney function requiring increased caution. There is a risk of acute pancreatitis with this medication, so if symptoms of pancreatitis occur, it should be stopped immediately and a physician consulted. Hypoglycemic symptoms may occur, so sugar should be consumed if symptoms arise and medical assistance sought if necessary. Additionally, if skin abnormalities such as blisters or ulcers occur, inform a physician immediately, and it is advisable to avoid alcohol consumption while on this medication. This medication is not recommended for children and adolescents and in cases of overdose, immediate medical attention should be sought. Finally, this medication should be stored out of reach of children and not transferred to other containers.

Side effects

  • Severe lactic acidosis
  • hypoglycemia
  • hepatitis
  • abnormal liver function
  • elevated transaminase levels
  • angioedema
  • tremors
  • headache
  • dizziness
  • fatigue
Show 44 more
  • nausea
  • hypoglycemia
  • gastroesophageal reflux
  • diarrhea
  • bloating
  • chills
  • reduced blood glucose
  • asthenia
  • hyperhidrosis
  • constipation
  • arthralgia
  • upper respiratory tract infection
  • nasopharyngitis
  • peripheral edema
  • nausea
  • vomiting
  • diarrhea
  • abdominal pain
  • decreased appetite
  • taste disturbance
  • erythema
  • pruritus
  • urticaria
  • pancreatitis
  • urticaria
  • blisters
  • exfoliative skin lesions
  • severe and disabling arthralgia
  • cutaneous vasculitis
  • cholecystitis
  • dyspepsia
  • abdominal discomfort
  • gastrointestinal abnormalities
  • increased serum amylase
  • increased lipase
  • vesicular bullous pemphigoid
  • myalgia
  • paresthesia
  • fever
  • edema
  • elevated creatine phosphokinase
  • elevated AST
  • increased C-reactive protein
  • elevated myoglobin levels

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture and should be kept in a cool place below 30 degrees Celsius. Proper storage will help maintain the medication's efficacy and prevent deterioration.

Appearance and packaging

Appearance

Yellow oval film-coated tablets

Package unit

Bottle - 30 tablets/bottle, Bottle - 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.